BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31568907)

  • 1. Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection.
    Ahn S; Park JS; Song JH; Jeun SS; Hong YK
    World Neurosurg; 2020 Jan; 133():e640-e645. PubMed ID: 31568907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W; Verma V; Butler EB; Teh BS
    Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma.
    Ahn S; Park JS; Jang J; Ahn KJ; Hong YK; Yang SH; Jeun SS
    J Clin Neurosci; 2020 Jan; 71():21-25. PubMed ID: 31843432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
    Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
    Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma.
    Matsuda M; Kohzuki H; Ishikawa E; Yamamoto T; Akutsu H; Takano S; Mizumoto M; Tsuboi K; Matsumura A
    J Clin Neurosci; 2018 Apr; 50():172-176. PubMed ID: 29396060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients.
    Zur I; Tzuk-Shina T; Guriel M; Eran A; Kaidar-Person O
    Sci Rep; 2020 Jun; 10(1):9595. PubMed ID: 32533126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and outcomes for glioblastoma in patients with poor performance status.
    Malakhov N; Lee A; Garay E; Becker DJ; Schreiber D
    J Clin Neurosci; 2018 Jun; 52():66-70. PubMed ID: 29576419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
    Jiang H; Zeng W; Ren X; Cui Y; Li M; Yang K; Elbaroody M; Lin S
    J Neurooncol; 2019 Aug; 144(1):127-135. PubMed ID: 31175579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide.
    Guler OC; Yıldırım BA; Önal C; Topkan E
    Indian J Cancer; 2019; 56(1):59-64. PubMed ID: 30950447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.
    Han SJ; Rutledge WC; Molinaro AM; Chang SM; Clarke JL; Prados MD; Taylor JW; Berger MS; Butowski NA
    Neurosurgery; 2015 Aug; 77(2):248-53; discussion 253. PubMed ID: 25856113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study.
    Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M
    Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of low-molecular weight heparin addition to concomitant chemoradiotherapy in the treatment of glioblastoma multiforme.
    Zincircioglu SB; Kaplan MA; Isikdogan A; Cil T; Karadayi B; Dirier A; Kucukoner M; Inal A; Yildiz I; Aggil F; Donmez O; Urakci Z; Pekkolay Z; Firat U
    J BUON; 2012; 17(1):124-7. PubMed ID: 22517705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.